Ruxolitinib With De-Intensified HLH-94 for the Treatment of Hemophagocytic Lymphohistiocytosis (HLH)

NCT06160791 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Hemophagocytic Lymphohistiocytoses

Interventions

DRUG: Ruxolitinib
DRUG: Etoposide
DRUG: Dexamethasone
PROCEDURE: Non-interventional Imaging
PROCEDURE: Research Biopsy
PROCEDURE: Biospecimen Collection

Sponsor

Jerry Lee, MD, MSc, MPhil

Collaborators

[object Object]
[object Object]